- 全部删除
您的购物车当前为空
ATWLPPR Peptide 是一种具有特异性 VEGFR2/KDR 七肽拮抗剂,能够结合VEGFR2(KDR/flk),有效阻断VEGF与KDR的结合,并抑制VEGF诱导的体内血管生成。在体外,该肽特异性地抑制人内皮细胞的增殖;在体内,则能彻底消除VEGF诱导的血管形成。

ATWLPPR Peptide 是一种具有特异性 VEGFR2/KDR 七肽拮抗剂,能够结合VEGFR2(KDR/flk),有效阻断VEGF与KDR的结合,并抑制VEGF诱导的体内血管生成。在体外,该肽特异性地抑制人内皮细胞的增殖;在体内,则能彻底消除VEGF诱导的血管形成。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
ATWLPPR Peptide 相关产品
| 产品描述 | ATWLPPR Peptide is a biologically active peptide functioning as a specific antagonist to VEGFR2/KDR. It binds to VEGFR2 (KDR/flk), thereby completely inhibiting VEGF binding to KDR and blocking VEGF-induced angiogenesis in vivo. Moreover, it selectively inhibits human endothelial cell proliferation in vitro and effectively abolishes VEGF-induced angiogenesis in vivo. |
| 分子量 | 839.98 |
| 分子式 | C40H61N11O9 |
| CAS No. | 272121-15-0 |
| Sequence | Ala-Thr-Trp-Leu-Pro-Pro-Arg |
| Sequence Short | ATWLPPR |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容